- Mechanism of Action (MOA)
- Binds the 50S ribosomal subunit → inhibits bacterial protein synthesis (bacteriostatic).
- Clinical Notes
- Atypical coverage (Chlamydia, Mycoplasma; Legionella in vitro only); can prolong the QT interval.
Sources
Reviewed September 2026- FDA label — FDA / DailyMed
Checked against the guideline or standard reference the exam keys to. If it has moved, use Report an error below.
All pharmacology